LADENBURG THALMANN FINANCIAL SERVICES INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2019$706,000
-0.1%
7,373
+20.0%
0.00%
-20.0%
Q3 2019$707,000
-18.8%
6,143
+21.7%
0.01%
-16.7%
Q2 2019$871,000
+13.9%
5,049
+11.3%
0.01%0.0%
Q1 2019$765,000
+90.3%
4,535
+10.3%
0.01%
+50.0%
Q4 2018$402,000
-35.3%
4,112
+13.9%
0.00%
-20.0%
Q3 2018$621,000
+80.5%
3,610
+18.1%
0.01%
+66.7%
Q2 2018$344,0000.0%3,0570.0%0.00%0.0%
Q1 2018$344,000
+6.8%
3,057
+25.4%
0.00%0.0%
Q4 2017$322,000
+9.5%
2,438
-15.6%
0.00%0.0%
Q3 2017$294,000
+51.5%
2,887
+49.5%
0.00%
+50.0%
Q2 2017$194,000
-17.1%
1,931
-0.8%
0.00%
-33.3%
Q1 2017$234,000
+7.3%
1,946
+1.6%
0.00%0.0%
Q4 2016$218,000
-7.2%
1,916
+8.0%
0.00%
-25.0%
Q3 2016$235,000
+30.6%
1,774
-9.9%
0.00%
+33.3%
Q2 2016$180,000
+27.7%
1,970
+0.5%
0.00%
+50.0%
Q1 2016$141,000
+15.6%
1,960
+12.3%
0.00%0.0%
Q4 2015$122,000
+23.2%
1,746
+62.1%
0.00%0.0%
Q3 2015$99,000
-41.4%
1,077
-21.6%
0.00%
-33.3%
Q2 2015$169,000
+32.0%
1,374
-1.5%
0.00%
+50.0%
Q1 2015$128,000
+814.3%
1,395
+554.9%
0.00%
Q4 2014$14,000
-63.2%
213
-54.7%
0.00%
-100.0%
Q3 2014$38,000
-65.1%
470
-53.9%
0.00%
-66.7%
Q2 2014$109,000
+808.3%
1,020
+410.0%
0.00%
Q1 2014$12,000
+50.0%
2000.0%0.00%
Q4 2013$8,0002000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders